Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ava Science Inc.

www.avawomen.com

Latest From Ava Science Inc.

Device/Diagnostics Quarterly Deal Statistics, Q4 2016

Medtech companies raised $2.4 billion in the fourth quarter, the second-strongest of the year; Q4 device M&A deals totaled $9 billion in value, led by Allergan's $2.9 billion buy of Acelity's LifeCell division. Diagnostics financings finished out the year at $721 million, an increase over the previous quarter and 2016's second-highest quarter, but diagnostics M&A activity was the lowest of the year at $87 million, with only two completed acquisitions.

Deals Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ava Science Inc.
  • Senior Management
  • Pascal Koenig, CEO
    Philipp Tholen, VP, Product & Operations
    Peter Stein, VP, R&D
    Lea von Bidder, VP, Mktg.
  • Contact Info
  • Ava Science Inc.
    77 Geary St.
    San Francisco, CA 94108
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register